MANKIND PHARMA
Back to Income Statement
|
MANKIND PHARMA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹2,515 Cr | ₹190,193 Cr | ₹1,991 Cr | ₹165 Cr | ₹14,447 Cr |
What is the latest Operating Profit of MANKIND PHARMA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹2,515 Cr |
| Mar2024 | ₹190,193 Cr |
| Mar2023 | ₹1,991 Cr |
| Mar2022 | ₹165 Cr |
| Mar2021 | ₹14,447 Cr |
How is Operating Profit of MANKIND PHARMA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,515 Cr | -98.68 | |
| Mar2024 | ₹190,193 Cr | 9,454.83 | |
| Mar2023 | ₹1,991 Cr | 1,107.04 | |
| Mar2022 | ₹165 Cr | -98.86 | |
| Mar2021 | ₹14,447 Cr | - | |
Compare Operating Profit of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹82,454.7 Cr | -1.1% | -11.1% | -16.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -1.1% |
-11.1% |
-16.9% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses